What Are the Future Directions for KSP Inhibitors?
The future of KSP inhibitors in cancer treatment is promising but requires further research and clinical validation. Potential directions include:
- Combination Therapies: Combining KSP inhibitors with other targeted therapies or immunotherapies could enhance their efficacy and overcome resistance. - Biomarker Development: Identifying biomarkers that predict response to KSP inhibitors could help personalize treatment and improve outcomes. - New Formulations: Developing more stable and effective formulations of KSP inhibitors could enhance their clinical utility.